DiscGenics (@DiscGenics) header
DiscGenics (@DiscGenics) profile picture

A clinical stage company developing regenerative therapies that alleviate pain and restore function in patients with degenerative diseases of the spine.

Salt Lake City, UT
Joined April 2014
We are excited to announce that the U.S. FDA has allowed Phase III clinical evaluation of our allogeneic, injectable disc progenitor #celltherapy (IDCT) for painful lumbar #degenerativediscdisease to proceed. Subject enrollment expected to begin Q4 2024. bit.ly/3xX8cv4
3
2
5
386
DiscGenics Chairman & CEO @flagg_flanagan to present at #CanaccordGenuity 2024 Musculoskeletal Conference prn.to/4bxu7ro #aaos2024
6
360
Thrilled to share highlights from our recent podcast with Merge Medical! Dive into the innovative world of DiscGenics and discover the transformative potential of IDCT. A must-listen for those passionate about the future of spinal health! #IDCT #RegenerativeMedicine #SpinalHealth
1
272
FDA grants Regenerative Medicine Advanced Therapy (#RMAT) designation to IDCT because of its potential to address the unmet medical needs of millions of patients with painful #degenerativediscdisease! https://xitter.gq/t.co/DdPSJkr0iV
2
1
1
12
1,021
Our CEO & Chairman @FlanaganFlagg will present an update on our recently completed US clinical study evaluating IDCT for #degenerativediscdisease at the 41st Annual J.P. Morgan Healthcare Conference on Wed., Jan 11, 2023 at 3:30PM. #JPM23 #JPM2023 prn.to/3i9REIc
4
781
#DiscGenics Senior Process Engineer is in Dublin this week presenting at the Global Bioprocessing, Bioanalytics & ATMP Manufacturing Congress (@lifesciences_GE) on container closure integrity testing for #celltherapy. global-engage.com/event/biop…
1
Positive interim clin data for allogeneic #celltherapy for #degenerativediscdisease presented at #SpineSummit2022. High dose IDCT well tolerated, resulted in statistically significant, clinically meaningful improvements in pain, function & quality of life https://xitter.gq/t.co/YeqF33uM2O
1
3
Our CEO & Chairman Flagg Flanagan will present an update on our US and Japanese clinical programs evaluating IDCT for #degenerativediscdisease at the 40th Annual J.P. Morgan Healthcare Conference on Tues., Jan 11, 2022 at 9:00AM EST. #JPM22 #JPM2022 https://xitter.gq/t.co/gZGKFRCZcp
4
We are pleased to announce our participation in #CGMesa21 this week. Our Chairman & CEO Flagg Flanagan will give an update on the company’s U.S. and Japanese clinical programs evaluating IDCT for #degenerativediscdisease TODAY at 3:15PM PT. Learn more meetingonthemesa.com
Excited to participate in the #ORS2021 virtual meeting! Our head of R&D will chair 2 Innovation & Commercialization sessions focused on regulatory & manufacturing considerations for orthopaedic product development. #celltherapy #discdegeneration #degenerativediscdisease
1
3
If you're attending the @alliancerm's #Mesa20 virtually this week, be sure to check out our Chairman & CEO’s company update, available on-demand all week: meetingonthemesa.com/company…
2
We're excited to be in Phoenix for #ORS2020! Check out our schedule of events to learn where you can meet members of our R&D team this week. Hope to see you there! #celltherapy #discdegeneration #degenerativediscdisease
3